Replies to post #9578 on Avid Bioservices Inc (CDMO)

[jazzbeerman]

jake,

Bavi would seem to overlap a few categories in that chart..

I agree the chances are even better. Also, the weakest area of that chart, phase 2, (and I sure wouldn't even call that weak when you consider traditional drugs in comparison!), but anyway- as to phase 2- small efficacy trials- I'm not too worried about bavi showing efficacy :)



j